O conteúdo desse portal pode ser acessível em Libras usando o VLibras


Oswaldo Cruz Foundation an institution in the service of life

Início do conteúdo

Fiocruz International News - March 2022

If you can't read this, click here
Fiocruz News

Bimonthly newsletter of the Fiocruz Global Health Center (Cris/Fiocruz)

March / 2022
The president of the Foundation, Nísia Trindade Lima, highlighted the need to decentralize vaccine production and reinforce investments in research and development during the event in London
The Foundation, through the Immunobiological Technology Institute (Bio-Manguinhos), provides the first doses of the vaccine produced with the national Active Pharmaceutical Ingredient. The first batch was released by the internal quality control on February 14th
The Fiocruz Genomic Network has released new data on the status of lineages and variants of the Sars-CoV-2 in Brazil, based on the genomic surveillance produced by its plataform and other initiatives
Research published in "The New England Journal of Medicine" found that children with Congenital Zika Syndrome are up to 11 times more likely to die, when compared to children without it, by their third year of life
An international team of scientists, led by the Oswaldo Cruz Institute in partnership with Microsoft AI for Health and the Novartis Foundation, has developed a diagnostic assistant which can help to identify suspected lesions
The authors of the article published in "Nature", including the president of Fiocruz, highlight that COVID-19 has made more evident the inequity in access to the benefits of research and the need to reorient the system
The initiative, led by the Fiocruz Genomic Network, will allow sharing data with other groups for comparison, neutralization assays and other research purposes
Countries with high vaccination coverage are adopting a dangerous rhetoric according to which the pandemic is over. But how can one state that when there are still 70,000 people dying of COVID-19 in a week, asks Mariângela Simão
With joint projects, Mexican institutions and Fiocruz will be able to increase cooperation, suggests consul Héctor Humberto Valezzi Zafra during a visit to the Official Residence of the Foundation
Published on "EClinicalMedicine", the result of the first clinical trial with selenium supplementation for patients with Chagas cardiopathy showed a potential benefit provided by the treatment in at least one subgroup of patients
Carlos Alberto Velástegui was at Fiocruz to strengthen ties between his country and the Foundation. Welcomed by President Nísia Trindade Lima, he was interested in raising areas for possible cooperation with Ecuadorian institutions

Fiocruz International News
Bimonthly report of the Fiocruz Global Health Center (Cris/Fiocruz), edited by the Fiocruz Coordination of Social Communication

Masthead | cancel subscription


Back to the topBack